Pharma & Biotech - Page 6

President Donald Trump has announced a phased tariff plan targeting generic drugs imported into the United States, beginning with a zero-tariff window starting August 1. Under the plan, generic drug imports will

Doceree has unveiled Semmelweis, a proprietary artificial intelligence reasoning and orchestration model built exclusively for pharmaceutical commercialisation and marketing. The model serves as the intelligence layer powering Daily Command, Doceree’s newly launched

Sanofi has unveiled a revised executive lineup set to take effect on 1 September, as newly installed CEO Belén Garijo moves to reshape leadership across the organisation. Garijo, a former CEO of

Amgen has agreed to a $74 million settlement to resolve a class action lawsuit alleging the biotechnology giant withheld critical tax liability information from investors for far too long. The preliminary settlement

Novo Nordisk has filed a federal lawsuit against Eli Lilly and Company and Lilly USA, LLC over national advertising campaigns for two of its flagship weight-loss drugs. The suit was filed in

Novartis chief executive Vas Narasimhan has expressed confidence in the long-term commercial prospects of the company’s injectable cholesterol-lowering treatment, Leqvio. His comments come in direct response to the recent regulatory approval of

Gilead Sciences and Merck have reported positive results from two phase 3 trials backing what could become the first long-acting oral HIV treatment taken once weekly. The combination regimen pairs Merck’s islatravir

Samsung Biologics, the South Korean contract drug manufacturer, is making a major move into the fast-growing weight loss drug market with a landmark acquisition worth $1.8 billion. The company has announced plans

Cencora’s senior vice president of global supply chain, Brent Wilhelm, is drawing attention to one of pharmaceutical distribution’s most persistent blind spots. Even when a therapy is correctly stocked and staged at